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ABSTRACT
Objectives: Identify important patient-reported concepts of dyspnea and
associated activities to develop a dyspnea-speciﬁc conceptual model for
chronic obstructive pulmonary disease (COPD).
Methods: Using grounded theory methodologies, we identiﬁed key con-
cepts through interviews with 25 COPD patients, review of scientiﬁc
literature, and input from 22 experts.
Results: Constant comparative thematic analysis of data suggested ﬁve
primary components of the dyspnea experience: breathlessness, fatigue,
activity modiﬁcation, activity limitation, and emotional response. Two
major inﬂuences on dyspnea were described as individual exertion and
exposure to environmental factors. Patients described a sense of dyspnea-
related fear, and reported distress over the impact of dyspnea on health
and activity limitation. They emphasized coping via behavioral strategies
and medication, and reported that dyspnea caused the stopping or scaling
back of activities, taking more time to do things and using adaptive
measures or equipment. No existing model of dyspnea in COPD incorpo-
rated all of these concepts. We, therefore, developed a dyspnea-speciﬁc
conceptual model in which the most proximal of concepts (dyspnea symp-
toms) can impair function and are mediated by personal and environmen-
tal factors.
Conclusion: Patient and expert input guided the development of a com-
prehensive dyspnea-speciﬁc conceptual model for COPD which will
inform the design of future patient-reported outcome measurement tools
used to assess dyspnea and related functional limitations.
Keywords: COPD, model, patient-reported outcomes, qualitative
research, quality of life.
Background
Chronic obstructive pulmonary disease (COPD) is a major public
health problem in the United States and around the world. Esti-
mates of the number of US patients affected by COPD range from
10 million to 24.5 million [1]. It is currently the fourth cause of
death in the United States, and a signiﬁcant degree of health-care
utilization is attributed to it, including some 726,000 hospital-
izations, 1.5 million visits to the emergency room, and approxi-
mately 8 million outpatient physician visits. COPD is also a
major source of disability and impaired health-related quality of
life (HRQL) [2].
COPD has been characterized by the existence of chronic
bronchitis or emphysema, which may contribute to airﬂow
obstruction [3]. COPD evaluations in both clinical and research
settings typically include both pulmonary function tests (PFTs)
and patient-reported symptoms, which have been underlined by
the American Thoracic Society [4], the British Thoracic Society
[5], and the Global Initiative for Chronic Obstructive Lung
Disease (GOLD) [6]. Airﬂow obstruction is measured with
spirometry; respiratory rate and oxygenation status, as measured
by arterial blood gases, can also be used as COPD indicators.
Interestingly, these objective measures of pulmonary functioning
do not correlate particularly well with patients’ reports of
COPD-associated symptoms [7]. The most prominent of these
symptoms is dyspnea or shortness of breath. Others include
coughing, excess sputum production, and wheezing.
Dyspnea, like other symptoms such as pain and fatigue, is
a subjective experience that can only be measured from the
patient’s perspective, because different people have different
thresholds for noticing, reporting, and rating the severity of the
symptom. That said, patient-reported dyspnea has proven difﬁ-
cult to measure. Although several general and disease-speciﬁc
self-report instruments have been developed, criticism from
research and clinical literature has highlighted an overall lack of
consensus and standardization [8]. Existing dyspnea measures
utilize a wide range of administration and response formats,
including structured interviews [9], self-report questionnaires
[10], visual analogue scales [11], and numeric rating scales [12].
Some focus on historical accounts of symptoms during a particu-
lar time period, while others seek an estimation of dyspnea-
related impairment as a result of activities of daily living (ADLs)
or induced by exercise [8]. Further, many existing measures are
limited [8,13] with drawbacks that include: 1) under evaluation
of important aspects of dyspnea, such as psychological and func-
tional factors; 2) reliance on open-ended and potentially biased
interviewer-led questions; 3) being time and labor intensive; 4)
having confusing instructions and scoring; 5) being unreliable
and insensitive; and 6) not accounting for activity modiﬁcation
and exertion.
The sheer range of different self-report measurement
approaches, in combination with the general lack of association
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between self-reported dyspnea and PFTs, underscores the need
for a conceptual model to elucidate the relationships between
dyspnea and other important factors that not only inﬂuence it,
but are also inﬂuenced by it. Once these relationships are iden-
tiﬁed and better understood, maybe then improvements can be
made to the manner in which dyspnea is assessed.
Importance of Starting with a Conceptual Model
A conceptual model is a theoretical representation which deﬁnes
the concepts of interest, their interfaces, and possible determi-
nants [14]. A conceptual model also lends structure, content,
coherence, and plausibility to the concepts being measured. In
developing a patient-reported outcome (PRO) measure of
dyspnea for people diagnosed with COPD, it is important that
the instrument: 1) be relevant and meaningful to patients; 2) be
conceptually grounded in the many factors at play in the expe-
rience of dyspnea; and 3) be embedded within a speciﬁc concep-
tual model that indicates the relationship between the patient-
focused outcomes and the other clinical trial assessments. This
article summarizes research activity surrounding the articulation
of patient-driven concepts dealing with dyspnea and related func-
tional limitations in patients with COPD.
Methods and Results
Unlike positivistic research, qualitative studies involving natural-
istic inquiry often utilize an iterative approach to data collection,
synthesis, and analysis [15]. As such, we have presented our
Methods and Results sections jointly, to best accommodate this
frequentative format. This study was approved by the local insti-
tutional review board of the participating research site. Our ﬁrst
task was to identify key concepts that can clearly and closely be
linked to COPD and its treatment. To elucidate and focus these
concepts, we conducted individual open-ended interviews with
people diagnosed with COPD using a snowball sampling tech-
nique. As a component of grounded theory methodology [16,17],
interview responses were examined systematically [18–20].
Audiotapes of interviews were transcribed verbatim, excluding
identifying information. Experts were convened to generate a
mutually agreeable list of themes and dimensions of major ideas
that were expressed by interviewees, contained in observation
notes, or are predeﬁned dimensions based on current available
literature. Using selective coding and constant comparative
methods, members of the study team participated in a nominal
group process to identify common themes, create deﬁnitions, and
develop coding rules regarding speciﬁc group comments. The
comments were then compiled and summarized in frequency
tables denoting the number of times certain responses were
made. Next, these concepts were reviewed by additional patients
diagnosed with COPD through “think-aloud interviews” [21],
which were designed to capture patient understanding and rel-
evance of concepts that populated the evolving draft conceptual
model. Data saturation had occurred during the ﬁrst 15 open-
ended interviews, which was evidenced by replication and re-
dundancy [22] of major concepts and meta-themes that later
populated the model. Consistent with recommended methods
for determining saturation [23], our criterion for a “saturated
concept” was met when it was mentioned by at least 70% of the
sample, which was achieved (the majority of concepts were men-
tioned by more than 80% of respondents). These results were
further conﬁrmed during the second round of “think-aloud inter-
views.” The result of these tasks led to the development of a
dyspnea-speciﬁc conceptual model as it relates to the patient
experience with COPD. The development process is outlined in
Figure 1. Details regarding procedure and results follow.
Concept Identiﬁcation
Open-ended individual patient interviews. Patients with COPD
were identiﬁed and recruited by a medical team member from
pulmonology, and COPD clinics and pulmonary function labs
within a large midwestern teaching hospital system. A trained
research assistant conducted face-to-face individual interviews,
which were audio recorded and later transcribed. The patients
began by answering the following open-ended questions: 1)
“What does ‘shortness of breath’ mean to you?” 2) “What makes
your shortness of breath worse?” 3) “What makes your shortness
of breath better?” 4) “Many people ﬁnd shortness of breath to be
distressing. How does shortness of breath affect you on that
level?” 5) “When you think about shortness of breath, what
limitations to your life or daily activities come to mind?” 6)
“When you thought about limitations in the previous question,
how were you limited?”
Fifteen COPD patients participated in open-ended individual
interviews. The majority of the participants were males (80%)
with a mean age of 81 (range = 72–92). All but one participant
was Caucasian, and most (67%) were married. All but two
participants attended at least some college and nearly all were
retired (87%). The average number of years diagnosed with
COPD was 14 (SD 14). The average GOLD standard was 4.7
(SD 1.0), and all reported a positive smoking history (mean = 46
pack years, SD 16) with only two current smokers.
Expert input. We employed two expert panels to support our
concept identiﬁcation process. Expert panel I provided assistance
with the thematic analysis of individual interview data. This
panel reviewed and organized the individual interview data into
meaningful units, and then grouped the patient-generated themes
into larger concepts, which became the foundation of the
Proposed Dyspnea-Specific 
Conceptual Model for COPD 
Individual Patient Think Aloud Interviews 
Draft Concepts 
Expert Input Literature Review 
Concept Identification via Individual Patient Interviews 
Figure 1 Conceptual model development process.
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dyspnea-speciﬁc conceptual model. Expert panel II provided
assistance and input into the model, including review of concepts
for their relevance and ﬁt to the clinical setting of COPD. A
subset of panel II experts completed a survey with test items that
were derived from evolving concepts to remark on the item’s
importance. Experts participated in several face-to-face and tele-
phone meetings as needed to reconcile the qualitative data from
patients and contribute to the substance of the evolving concep-
tual model.
Expert panel I (n = 6) included one US-based clinical COPD
expert, four measurement experts with qualitative research expe-
rience, and one cross-cultural expert. Expert panel II (n = 16)
was comprised of ﬁve US-based clinical COPD experts, seven
international clinical COPD experts, three measurement experts,
and one cross-cultural measurement expert. Of these 16 expert
panel members, 7 clinical experts (three US based; four interna-
tional) also completed a survey of test items to comment on
relevance. See Tables 1–6 for patient comments that were
organized into thematic concepts by outside experts and study
investigators.
Literature review. Concurrent with the qualitative research
described earlier, we conducted a MEDLINE literature review to
identify and examine existing models of dyspnea or COPD that
might help explain the patient experience with COPD. Eight
different models were identiﬁed, including: 1) a model for orga-
nizing the phenomena related to dyspnea [24]; 2) a model of
dyspnea [25]; 3) a model for operationalizing dyspnea [26]; 4) an
ecologic model of the dyspnea experience [27]; 5) antecedents
and reactions to dyspnea [28]; 6) explanatory model of func-
tional status in COPD [29]; 7) a model of chronic dyspnea [30];
and 8) functional status model of COPD [31]. Each is brieﬂy
reviewed as follows.
Table 1 What does shortness of breath (SOB) mean to you?
Sample patient statements Concept
I cannot do the activities as easily as I used to. Activity limitation
Inability to perform certain activities, particularly
walking
Not being able to do my normal day-to-day activities
I have to stop what I am doing.
Everything I do is limited because I am weaker.
Everything is affected by breathing.
Everything I do is affected except when I am lying
perfectly still.
I start panting. Breathlessness
I cannot breathe.
Inability to breathe without stress
Cannot seem to get enough oxygen
I might walk across the room and have SOB, 50 ft. Exertion
When I walk up/down stairs, I breathe very heavily.
If I have to hurry, I get SOB.
Any kind of exertion
Exercising
You cannot take full breaths. Incomplete breathing
Not being able to inhale a normal breath
I lose control of my bodily functions, such as bladder. Loss of different
bodily functionsBlowing my nose is impossible because of SOB.
Very low stamina with least exertion Low stamina/energy
It wipes me out.
Everything is tiresome.
I associate it with my heartbeat. Related to heart
My heartbeat becomes excessively high.
I get relief from the meds I get from my doctors. Taking medications
I have to stop and catch my breath. Time extension
You have to sit down to catch your breath until you
can breathe again.
Those things you do, you do slower because it causes
SOB.
It is a choking sensation. Uncomfortable
sensationHufﬁng and pufﬁng
I have to turn up the oxygen so that I can breathe
better.
Use of assistive
devices
First thing you ask for is oxygen.
Table 2 What makes your shortness of breath (SOB) worse?
Sample patient statements Concept
Being at the airport Activity requirements
Climbing stairs Daily activities
Walking
Talking
Walking on an incline
Rapid movement
Lifting
Shopping
Making my bed
Making coffee
Doing the laundry
Going to the bathroom
Doing the dishes
Smoke has a big inﬂuence Environmental factors
Cold air
When it is too hot outside
Change of seasons
Pollen
Freshly cut grass
Cats
Birds make me SOB
Exertion Exertion
Exercise
Table 3 What makes your shortness of breath better?
Sample patient statements Concept
Going inside Activity requirements
Oxygen Assistive devices or resources
Doing pulmonary rehab
Using a wheelchair
Taking deep breaths Behavioral coping strategy
Relaxing
Breathing through the nose
Trying to breathe as normal as possible
Medication Medication
Using inhalers
Not forcing myself to walk more
than needed
Rest
Rest
Sitting down
Table 4 Many people ﬁnd shortness of breath distressing. How does it
affect you on that level?
Sample patient statements Concept
It is distressing because I cannot do my
daily activities.
Distress about activity limitation
It is frightening to me. Fear of breathlessness
It is scary.
I panic when I get short of breath.
Very traumatic
It means feeling incompetent. Feeling ineffective
Feel frustrated Frustration
I am distressed. General distress
You do not want anything to aggravate it. Vigilance
Paranoid about walking
Worry about heart and health Worry about health
Worry about heart or asthma
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Model for Organizing the Phenomena Related to
Dyspnea [24]
This model offers several ways to identify and examine dyspnea
risk factors, which are labeled personal, health, and situational
variables. Personal variables related to dyspnea include socioeco-
nomic status (SES) and smoking history; health refers to illness
duration, exercise tolerance, and pulmonary function; and situ-
ational variables include social support and inhalant exposure.
Moderators include coping, self-care behaviors, and therapeutic
management strategies. Although this model describes dyspnea
risk factors, it does not provide methods to describe and measure
these phenomena. Even though many of the mentioned variables
might be outcomes of dyspnea, a feedback loop from dyspnea to
these areas would be important.
Model of Dyspnea [25]
This model contains ﬁve elements reﬂecting the dyspnea experi-
ence, which include: dyspnea sensation (mediated by sensory
receptors and central nervous system), dyspnea perception
(affected by one’s experience and adaptation), dyspnea distress,
dyspnea response (coping), and dyspnea reporting (descriptors of
the experience). Although comprehensive in describing the
dyspnea experience, it does not address precipitating factors, risk
factors, or consequences of dyspnea on a person’s quality of life.
Also, it does not include duration or intensity of dyspnea.
Model for Operationalizing Dyspnea [26]
This model posits that dyspnea sensation and reaction occur
through psychological and physiological experiences that are
innervated by one’s culture, environment, perception, and psy-
chological state. Hypothesized consequences of these interactions
are resolution of the dyspnea sensation (person takes some action
such as stopping the activity); adaptation of the dyspnea sensa-
tion (person takes some action to mediate reaction, but does not
completely resolve it); and no response, in which an action has no
effect on the dyspnea sensation. The outcome of this model is the
degree of dyspnea, which is mediated by one’s coping strategies
versus how dyspnea might impact a person’s quality of life.
Similar to the previous models, the consequences of dyspnea are
not explicitly stated.
Ecologic Model of the Dyspnea Experience [27]
This model characterizes dyspnea as a biopsychosocial occur-
rence in which environmental factors (SES, social support, inhal-
ant exposure) interact with risk and resilience factors (disease,
perception, coping). This interaction affects functioning and
dyspnea tolerance. This model contains multiple feedback loops
that connect predisposing factors with outcomes, but views poor
physical functioning and social isolation as mediators of dyspnea
instead of long-term outcomes, which make them difﬁcult to
target in an intervention.
Antecedents and Reactions to Dyspnea [28]
Not necessarily viewed as a model, this schema depicts the
antecedents and reactions to one’s dyspnea experience. The ante-
cedents include physiological (cardiac, pulmonary, and neuro-
muscular disease) and psychological factors (anger, anxiety,
depression), which are believed to make breathing more labor
intensive and disrupt gas exchange. Reactions are also physi-
ological (tachypnea, tachycardia, sensory muscle use, tidal
volume changes) and psychological (panic, frustration, anxiety,
Table 5 When you think about shortness of breath, what limitations to
your life or daily activities come to mind?
Sample patient statements Concept
Carrying groceries Carrying
Carrying things
Climbing ladders Climbing
Climbing stairs
Combing hair Personal hygiene
Washing hair
Showering
Taking a bath
Getting dressed Dressing
Driving a car Driving
Eating Eating
Looking at the stock market Finances
Getting in and out of a car Transfers
Getting out of chairs
Getting out of bed
Going out Participation
Restricted from being around friends
Going to dinner
Daily social activities
Height (1000 s of feet—extremes) Heights
Hobbies (golf and skiing) Recreation
Playing tennis
Chores around the house Household chores
Daily chores
Taking out garbage
Laundry
Raking leaves
Shoveling snow
Lifting objects Lifting
I have to take my meds. Medications
Mobility Mobility
Reaching up on shelves Reaching
Sitting Sitting
Taking any length of time Talking
Traveling Traveling
Using the bathroom Toileting
Taking long walks Walking
Walking any kind of distance
Walking more than one-half block
Walking more than two blocks is an effort
Walking across the room
Table 6 When you thought about your limitations in the previous
question, how were you limited?
Sample patient statements Concept
Climbing stairs Climbing
Eating Eating
Exercise Exertion
Getting dressed Dressing
Heights Heights
Any bodily functions are difﬁcult now Loss of different bodily functions
Energy level is substantially less Low stamina/energy
Personal hygiene Personal hygiene
Taking a shower
Shoveling snow Household chores
Using snow blower
Talking Talking
Talking on the phone
Not doing things as often Task avoidance
Avoid certain activities entirely
Avoiding stairs
Stop doing certain activities
Takes longer to do daily activities Time extension
Have to rest more
Taking longer to do things
Travel Traveling
Hufﬁng and pufﬁng Uncomfortable sensation
Walking (40 steps) Walking
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anger, and fear). One of the biggest reported limitations of this
schema is its inability to describe ways in which dyspnea’s con-
sequences can negatively impact a person’s quality of life.
Explanatory Model of Functional Status in COPD [29]
This empirically derived model tests several important physi-
ological and psychological variables (length of illness, age,
dyspnea, pulmonary function, oxygen desaturation during exer-
cise, exercise capacity, anxiety, self-esteem, and depressed mood)
to clarify their explanatory role in one’s functional status in
COPD. In one study, exercise capacity not only demonstrated the
strongest direct relationship to functional status (b = 0.34), but
also served as a common pathway for pulmonary function
(b = 0.42), dyspnea (b = 0.49), and depressed mood (b = 0.22).
Dyspnea and depressed mood also directly inﬂuenced functional
status (b = 0.32 and -0.20, respectively). In addition to anxiety
and self-esteem’s inﬂuence on depressed mood (b = 0.70 and
-0.50, respectively), anxiety was also positively associated with
the dyspnea experience (b = 0.25). Overall, the authors recom-
mend that future interventions focus on exercise capacity,
dyspnea, and emotional factors such as depression and anxiety.
Model of Chronic Dyspnea [30]
This model focuses on the experience of chronic dyspnea and is
comprised of three major components, which include physiologic
antecedents, dyspnea, and consequences. The antecedents
include hyperinﬂation, increased airway resistance, and de-
creased lung compliance, which are considered to be minor
aspects of the model as they are often difﬁcult to treat once
chronic dyspnea has developed. At the heart of this model is the
perception of persistent shortness of breath, which can vary in
intensity and be affected by intermittent episodes of acute
dyspnea. Consequences are divided into physical (reduced activ-
ity, reduced ADLs, fatigue), psychological (role loss, depression)
and sociocultural (isolation, occupational). Compared to acute
dyspnea in which psychological aspects such as fear and panic
play a larger role in precipitating an exacerbation, in chronic
dyspnea, psychological aspects such as depression are more the
consequence of living with unrelenting distress.
Functional Status Model of COPD [31]
The functional status model of COPD is an empirically tested
model that examines the relationships between exogenous vari-
ables (disease severity, dyspnea) and endogenous variables (age,
exercise tolerance, fatigue, psychiatric variables, health percep-
tion, and functional independence) using structural equation
modeling. In their study, functional performance was inﬂuenced
directly by age (b = -0.15), exercise tolerance (b = 0.49), health
perception (b = 0.15), negative mood (b = -0.17), and dyspnea
(b = -0.12). Several other indirect relationships were also
reported. For example, exercise tolerance was inﬂuenced by age
(b = -0.15), disease severity (b = 0.27), health perception
(b = 0.17), and negative mood (b = -0.34). Dyspnea inﬂuenced
fatigue (b = 0.32) and negative mood (b = 0.22), while disease
severity inﬂuenced dyspnea (b = -0.20). Although limited by a
relatively small convenience sample, these ﬁndings conﬁrm pre-
vious studies and suggest that improving dyspnea would lead to
several other areas of improvement, including fatigue, mood,
exercise tolerance, and functional ability.
Despite the existence of several extant models of dyspnea in
COPD, none meet all of the features elucidated by patients in our
qualitative research. We therefore created a unique dyspnea-
speciﬁc conceptual model, which was guided by the qualitative
data and informed by pre-existing research and other conceptual
models.
Individual Patient Think Aloud Interviews
Next, to assess understandability and relevance of the emerging
concepts, the patients were asked to “think aloud” about them in
the context of their daily lives. They were also asked to answer
sample questions and share their thought processes on why they
answered as they did, including how they arrived at their answer.
This is a commonly practiced qualitative interviewing technique
[32,33] that is different from a semistructured interview in that
patients are not elaborating on a series of prearranged questions,
per se, but rather talking and thinking out load in an open-ended
fashion about particular concepts and how they understand
them. Through this process, the patients were encouraged to
express their experience with dyspnea, including its severity and
its impact on functional activities, their emotions, any limitations
or avoidance of activities, and their motivation to engage in
activities versus a preference they might have for sedentary
behavior. Responses were transcribed and summarized to help
deepen existing concepts in the model.
Patient “think aloud” interviews (n = 10) were completed by
10 people diagnosed with COPD. The majority of participants
were females (60%) with a mean age of 71 (range = 59–79). All
but two participants were Caucasian and the majority lived with
others (70%). Most had attended at least some college (70%),
and half were retired. The average number of years diagnosed
with COPD was 9 (SD 10). The average GOLD standard was 4.4
(SD 1.4), and all but one reported a positive smoking history
(mean = 40 pack years, SD 11) with only one current smoker.
Below are some sample comments in areas covered by the evolv-
ing model.
Functional activities. “Getting up and down, I would say there is
more of a moderate shortness of breath. There is an increase in
shortness of breath (more) than when I am sedentary, sitting
down, but it is a matter of getting up and down in the bathtub
after I am in the bathtub.”
Emotions. “I have had nightmares and ﬂashbacks of it [dyspnea]
and being deathly afraid of not being able to breathe. Every week
or so, I take a half a pill to help me calm down and not be afraid
of it.”
Activity limitation/avoidance. “I no longer will clean the house.
. . . Because it was just getting to be too much.”
Activity motivation and sedentary behavior. “[sitting] I would
say probably between 80% and 90% of the day.”
Drafting a Dyspnea-Speciﬁc Conceptual Model
We began with the model provided by Wilson and Cleary [34].
This model is general and fairly linear/causal, and lends itself to
modiﬁcation based on individual disease and treatment consid-
erations such as those that exist with COPD. From this starting
point, we built a dyspnea-speciﬁc model that included input from
literature review ﬁndings, qualitative research with COPD
patients, and expert input. Brieﬂy, the Wilson and Cleary [34]
model of disease and PROs integrates psychological and biologi-
cal components of health outcomes. It includes ﬁve primary
components: 1) biological and physiological variables; 2)
symptom status; 3) functional status; 4) general health percep-
tions; and 5) HRQL.
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The authors hypothesize a causal relationship beginning with
the biological and physiological variables and ending with HRQL
after direct impact on the most proximal of concepts (symptoms)
which in turn can impair function and one’s perceptions of health.
Modiﬁcation (mediation) of the causal chain attributed to per-
sonal and environmental factors is also key to a comprehensive
and clear understanding of the linkages from biological disease to
perceived HRQL. Symptoms, functional status, general health
perceptions, and HRQL can all be inﬂuenced by personality or
other characteristics of the individual. They can also be inﬂuenced
by the environment and other nonmedical factors. The potential
inﬂuence of these nonmedical factors increases as one move to the
right in the model from symptoms in the model, toward more
general health and quality-of-life perceptions. The simplicity and
elegance of this model made it a useful starting point for our
dyspnea-speciﬁc model, as it encompassed all of the patient com-
ments in our qualitative research.
The ﬁrst component of the model: “biological and physiolo-
gical variables,” while extremely relevant to COPD-related
dyspnea, are best measured objectively. Therefore, this compo-
nent of the model was not a major focus for this work. The
“symptom status” component of the model seemed to corre-
spond well with “breathlessness” and “fatigue.” The “physical
functional status” component of the Wilson and Cleary model
corresponded with “activity limitation” as generated from the
open-ended patient interviews. “Characteristics of the indi-
vidual” in the model encompassed emotional responses to
dyspnea and personal preferences for task exertion. “Character-
istics of the environment” captured external inﬂuences on
dyspnea such as environmental toxins, use of adaptive devices,
and the demands of a given activity. Model elements to the far
right, including “general health perceptions,” “quality of life,”
and “nonmedical factors” emerged as themes, but tended to be
expressed as secondary to the functional impact of the disease,
and to emotional reactions and concerns about future health and
function. General health perceptions tended to emerge in the
context of expressed worry or sadness regarding one’s health.
Generic “nonmedical factors” such as sociocultural conditions
(crime, poverty, living situation) were only raised in the context
of those that had impact upon COPD (i.e., environmental factors
such as pollution, smoke, etc.). With the exception of the envi-
ronmental inﬂuences on symptoms and function, these factors
are less direct compared to the effects of disease and are, there-
fore, not a major focus of the scale development.
Dyspnea-Speciﬁc Conceptual Model for COPD
The synthesis of patient input, expert input, and literature review
led to the dyspnea-speciﬁc conceptual model of COPD as
depicted in Figure 2.
Biological and Physiological Variables
This component was adapted from the Wilson and Cleary start-
ing point to include pulmonary, cardiac, and muscular function.
In the presence of respiratory disorders, impairments in ventila-
tory and gas exchange processes restrict the aerobic capacity of
the exercising muscle and are frequently considered to limit
exercise performance. Nevertheless, while these boundaries are
approached during maximum exercise, they are seldom reached
in everyday life, and functional limitation is a common conse-
quence of impairment through the sensory system. During activi-
ties involving large muscle groups, in which there is a marked
ventilatory demand, there is a sense of discomfort closely related
to inspiratory muscle activity (e.g., exertional dyspnea). In situ-
ations where the degree of exertional dyspnea exceeds that which
an individual is willing to tolerate, activity is volitionally termi-
nated. Hence, exertional dyspnea may be viewed as a proximal
limitation to muscular performance. In COPD, excessive inspira-
tory effort and exertional dyspnea may be caused by increased
activity of the inspiratory muscles caused by added mechanical
loads, increased velocity of contraction at shortened muscle
length, mechanical disadvantages imposed on the diaphragm,
and reduced efﬁciency of gas exchange.
Dyspnea. This component encompasses the patient experience
of shortness of breath as inﬂuenced by biological and physiologi-
cal variables. The term “dyspnea” reﬂects the focus on this
cardinal symptom of COPD, including its intensity and fre-
quency, as well as the duration of a given dyspneic episode. It
considers the effects of excessive symptoms during everyday
activities, in which power output can be controlled by the exer-
cising individual. Disabled subjects have the option of either
selecting the same power output and tolerating higher symptom
intensity (and associated discomfort), or selecting a lower power
output and maintaining the same symptom intensity, which will
increase the time taken to complete a given task. Symptom inten-
sity is not only related to power output, but also to the duration
of activity, such that extending the time taken to complete the
task will also have a sensory cost. Nevertheless, the sensory cost
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of increasing the duration of activity is dramatically less than the
cost of increasing the power output. In either case, the disabled
patient is handicapped by excessive symptoms during exercise,
and reports this as a negative effect of exertional tasks. The
magnitude of the negative effect is dependent upon a unique
combination of the patient’s individual characteristics and the
characteristics of the environment that inﬂuence the symptom
experience as well as the impact of the symptom upon functional
ability.
Functional limitations. This dimension reﬂects the Wilson and
Cleary (1995) general concept of “physical functional status,”
but makes it more speciﬁc to the “functional limitations” asso-
ciated with dyspnea. It represents and can be affected by the
magnitude of the task and effort needed to perform certain
activities. Individuals stop exercising when they are no longer
willing to tolerate the discomfort associated with continuing the
activity. Given that the capacity to tolerate discomfort is likely
to be variable across subjects within the study population, in
part as a consequence of varying levels of motivation, symptom
magnitude at maximal exercise should be highly variable. We
can consider the effects of excessive symptoms during everyday
activities, in which the power output can be controlled by the
exercising individual. Disabled subjects have the option of either
selecting the same power output and tolerating higher symptom
intensity (and associated discomfort), or selecting a lower power
output and maintaining the same symptom intensity, which will
increase the time taken to complete a given task. Symptom
intensity is not only related to power output associated with
function, but also to the duration of activity, such that extend-
ing the time taken to complete the task may also reduce the
level of dyspnea. In this situation, the resultant increase in
power output is preferable to the symptom intensity induced by
performing the task more quickly. Whether the task is per-
formed quickly at a greater intensity level or more slowly and at
lower intensity, the disabled patient is handicapped by excessive
symptoms during exercise.
“Task avoidance” can be viewed as a component of func-
tional limitation. It reﬂects a person’s decision to stop engaging
in certain activities when the discomfort associated with continu-
ing the activity can no longer be tolerated. The capacity to
tolerate discomfort varies across individuals and will contribute
to one’s rating of functional capability or limitation. If one’s
tolerance threshold is exceeded, he/she may report avoiding
activities because of dyspnea.
“Time extension” on a task can also be reported. When
factors such as biological/physiological determinants, emotional
status, and dispositional tendencies toward physical activity (e.g.,
how naturally sedentary or active a person is) are taken into
account, the amount of time necessary to complete a task can
indicate the challenge of a given task. A direct measure of task
challenge would require some types of physiological assessment
(via heart rate monitors, doubly labeled water, accelerometers, or
pedometers). Asking people to report whether they are spending
more or less time on a given standard task or on “usual activi-
ties” can serve as a reasonable operational deﬁnition as to
whether there has been a meaningful increase or decrease in the
duration of time needed to perform a given task. Self-reported
time extension can provide an estimate of how challenges of a
given task inﬂuence the severity of dyspnea symptomatology and
related functional limitations.
Characteristics of the individual. Individual differences in psy-
chological and motivational factors can have an inﬂuence on
responses to questions regarding dyspnea and related functional
impairment. These differences can also be inﬂuenced by an indi-
vidual’s limitations and perceptions about their general health
and HRQL. This dimension incorporates emotional reactions to
dyspnea, including anxiety, fear, panic, and depression. It also
includes one’s general dispositional style related to activity moti-
vation (i.e., whether a person has a greater tendency or prefer-
ence toward being active or sedentary), despite symptoms of
dyspnea. These factors are hypothesized to directly inﬂuence
dyspnea severity, functional limitations, health perceptions, and
quality of life, and be affected by functional limitations, health
perceptions, and quality of life. The arrows in the proposed
conceptual depict these expected linkages.
Characteristics of the environment. The environment of the indi-
vidual can have a direct effect upon the experience and reporting
of dyspnea and functional limitations. Environmental factors,
including exposure to airborne allergens, pollutants, and smoke,
can exacerbate problems with symptoms and function. Other
environmental factors also exert direct causal effects on the con-
cepts of interest, namely the availability and use of assistive
devices (oxygen; walking aids), and external activity demands on
the person (such as work or other activity requirements). These
factors are hypothesized to directly inﬂuence dyspnea severity,
functional limitations, health perceptions, and HRQL, and there-
fore should be accounted for in a comprehensive conceptual
model of assessment in a clinical trial.
Conclusion
A patient-centered approach to understanding dyspnea in the
context of COPD is essential to evaluating disease and treatment
effects. We have found that qualitative input from patients and
experts ﬁts well into a new dyspnea-speciﬁc conceptual model,
which lends itself to future applications in the design of a con-
ceptual framework and PRO instrument. This model represents
the relationship between dyspnea and potential critical clinical
trial components, such as characteristics of the individual and
environment, biological and physiological variables, task chal-
lenge, and general health perceptions and HRQL.
This study is not without limitations. One factor that was
largely related to the geographic location of the participating
hospitals was the sex and age of the participants who were
recruited using a purposive, snowball sampling procedure. The
“open-ended” interviews were conducted with patients who
were primarily white males with an average age of 81, whereas
the “think aloud” interviews were conducted with mostly female
participants, approximately 10 years younger than the patients in
the “open-ended” group. A second potential limitation is the
sample size of 25 participants with COPD. Although a sample
size such as this is not uncommon in qualitative research (com-
pared to positivistic studies requiring powered sample sizes to
detect statistically signiﬁcant ﬁndings), future developments and
modiﬁcations of this model will beneﬁt from additional perspec-
tives from this patient population.
Having established a working explanatory model for the
patient experience with COPD, our next step is to develop a new
instrument to measure the PRO components of the conceptual
model. Our intention is to focus more precise measurement (typi-
cally requiring more items) on concepts such as dyspnea and
related functional limitations. Therefore, next steps include the
development and testing of large pools (item banks) of questions
to measure dyspnea and related functional limitations, which
could be analyzed to select the “best in class” going forward into
measures tailored to COPD patient populations in clinical trials.
It is important to appreciate that by design, an item bank is
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overpopulated with questions that represent the concept or
“trait” being measured. Therefore, one rarely needs to adminis-
ter all items in the bank to achieve a valid score. This opens one
up to the opportunity to create “short forms” for clinical
research from a subset of items. Assuming one demonstrates
unidimensionality of the concept being measured and ﬁt of the
measurement model as applied to the validation data, an inves-
tigator can select items freely from the bank to form a unique
scale that measures the concept represented by the bank. Because
the items are aligned along a continuum of the trait being mea-
sured, such as functional limitation, one could select all items
from a restricted area of the continuum (e.g., very demanding or
very easy tasks), or across a broad range of function, and in
either case obtain a common functional limitation score for the
person on answering the question. Items that are better targeted
to the study sample will provide a more accurate score than items
that are not well targeted. The expectation is that this instrument
would have applicability for measuring meaningful change in
dyspnea and related functional limitations among COPD
patients receiving treatment.
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